
Profitability, historical returns, and peer comparisons.
According to Health Advance Inc.’s latest financial reports and current stock price. The company's current ROE is 55.38%. This represents a change of 314.72% compared to the average of 13.35% of the last 4 quarters.
The mean historical ROE of Health Advance Inc. over the last ten years is -380.29%. The current 55.38% ROE has changed -114.56% with respect to the historical average. Over the past ten years (40 quarters), HADV's ROE was at its highest in in the June 2023 quarter at 297.96%. The ROE was at its lowest in in the December 2022 quarter at -494.32%.
Average
-380.29%
Median
49.76%
Minimum
-3831.39%
Maximum
147.66%
Discovering the peaks and valleys of Health Advance Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 682.73%
Maximum Annual ROE = 147.66%
Minimum Annual Increase = -4644.84%
Minimum Annual ROE = -3831.39%
| Year | ROE | Change |
|---|---|---|
| 2026 | 47.51% | -15.70% |
| 2025 | 56.36% | -51.73% |
| 2024 | 116.77% | -103.05% |
| 2023 | -3831.39% | 682.73% |
| 2022 | -489.49% | -4644.84% |
| 2021 | 10.77% | -41.81% |
| 2016 | 18.51% | -64.41% |
| 2015 | 52.01% | -24.00% |
| 2014 | 68.43% | -53.66% |
| 2013 | 147.66% | -55.72% |
The current ROE of Health Advance Inc. (HADV) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
73.54%
5-year avg
-820.05%
10-year avg
-380.29%
Health Advance Inc.’s ROE is greater than Rising Biosciences, Inc. (-4.43%), less than AXM Pharma, Inc. (0%), less than CeCors, Inc. (733.40%), greater than Immunotech Laboratories, Inc. (-9.01%), greater than Isodiol International Inc. (-427.45%), greater than Abattis Bioceuticals Corp. (-26.96%), greater than Spencer Pharmaceutical Inc. (-50.17%), less than Nanobac Pharmaceuticals, Incorporated (357.99%), less than OWC Pharmaceutical Research Corp. (237.20%), greater than Decision Diagnostics Corp. (-10388.57%),
| Company | ROE | Market cap |
|---|---|---|
| -4.43% | $4.99K | |
| 0% | $40.86K | |
| 733.40% | $1.46M | |
| -9.01% | $114.99K | |
| -427.45% | $4.91K | |
| -26.96% | $14.33K | |
| -50.17% | $29.44K | |
| 357.99% | $24.95K | |
| 237.20% | $4.97K | |
| -10388.57% | $35.79K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Health Advance Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Health Advance Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Health Advance Inc.'s ROE?
How is the ROE calculated for Health Advance Inc. (HADV)?
What is the highest ROE for Health Advance Inc. (HADV)?
What is the 3-year average ROE for Health Advance Inc. (HADV)?
What is the 5-year average ROE for Health Advance Inc. (HADV)?
How does the current ROE for Health Advance Inc. (HADV) compare to its historical average?